These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1387127)

  • 21. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW; von Borstel R
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E; Zinn S; Boarman D; Allegra CJ
    Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
    Chen TL; Erlichman C
    Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectivity of action of 5-FU: biochemical basis.
    Rustum YM; Danhauser L; Wang G
    Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase.
    Morgan RG
    Cancer; 1989 Mar; 63(6 Suppl):1008-12. PubMed ID: 2521810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells.
    Link KH; Aigner KR; Peschau K; Warthona M; Schwemmle K; Danenberg PV
    Cancer Chemother Pharmacol; 1988; 22(1):58-62. PubMed ID: 2969305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts.
    Taverna P; Rendahl K; Jekic-McMullen D; Shao Y; Aardalen K; Salangsang F; Doyle L; Moler E; Hibner B
    Biochem Pharmacol; 2007 Jan; 73(1):44-55. PubMed ID: 17046720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
    Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.
    Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
    Ishitsuka H; Miwa M; Takemoto K; Fukuoka K; Itoga A; Maruyama HB
    Gan; 1980 Feb; 71(1):112-23. PubMed ID: 6445847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MTX-5-FU combination therapy compared to FUDR monotherapy in nude mice.
    Zanea-Wangler E; Schmitz R; Kesseler J; Ploss HJ
    Strahlenther Onkol; 1989 Jul; 165(7):544-6. PubMed ID: 2526380
    [No Abstract]   [Full Text] [Related]  

  • 32. On the differential affinities of two anticancer analogues to their target.
    Holl E; Zänker KS; Lange J; Siewert JR
    Drugs Exp Clin Res; 1985; 11(2):133-9. PubMed ID: 2941256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Fluorouracil plus leucovorin as adjuvant treatment of an experimental liver tumor in rats.
    Carlsson G; Gustavsson BG; Spears CP; Hafström LO
    Anticancer Res; 1990; 10(3):813-6. PubMed ID: 2369095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
    Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
    Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate.
    Bowen D; Bailey BD; Guernsey LA
    Eur J Cancer Clin Oncol; 1984 May; 20(5):651-7. PubMed ID: 6234172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil.
    Peters GJ; van der Wilt CL; van Groeningen CJ; Smid K; Meijer S; Pinedo HM
    J Clin Oncol; 1994 Oct; 12(10):2035-42. PubMed ID: 7931471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.
    el Hag IA; Roos G; Jönsson PE; Stenram U
    Anticancer Res; 1990; 10(1):29-32. PubMed ID: 2139770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competitive binding radioassay for the determination of 5-fluorodeoxyuridine and 5-fluorodeoxyuridine-5'-monophosphate levels in plasma and tumor tissue.
    Miyata S; Mikami H; Tai M; Hori T; Fujita H
    Jpn J Cancer Res; 1991 Jun; 82(6):742-6. PubMed ID: 1830300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hyperthermia on the metabolism of 5-fluorouracil in vitro.
    Maeta M; Sawata T; Kaibara N
    Int J Hyperthermia; 1993; 9(1):105-13. PubMed ID: 8433020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of resistance to fluoropyrimidines.
    Zhang ZG; Harstrick A; Rustum YM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):4-9. PubMed ID: 1532673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.